| A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis (NCT05382819) | Fresh Tracks Therapeutics, Inc. | 2022-05-16 |
| Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% (NCT05461456) | OrchestratePharma GmbH | 2022-04-01 |
| Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children (NCT06361992) | Catalysis SL | 2022-03-15 |
| Metal Panel Allergen Patch Test Study (NCT04500834) | Allerderm | 2022-02-07 |
| Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic Dermatitis (NCT05136261) | KK Women's and Children's Hospital | 2022-01-10 |
| Clinical Trial to Evaluate the Efficacy and Safety of an Ozonated Oil in Atopic Dermatitis (NCT07744516) | Laboratorios Ozoaqua | 2021-09-22 |
| China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project (NCT05316805) | Peking University First Hospital | 2021-08-31 |
| Seal, Stopping Eczema and Allergy Study (NCT03742414) | Kari Nadeau, MD, PhD | 2021-06-30 |
| Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED) (NCT04845620) | Arcutis Biotherapeutics, Inc. | 2021-04-07 |
| Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (NCT04804605) | Arcutis Biotherapeutics, Inc. | 2021-02-25 |
| Hand Sanitizer Effects on the Skin Barrier (NCT04525521) | National Jewish Health | 2020-12-01 |
| Tofacitinib for Immune Skin Conditions in Down Syndrome (NCT04246372) | University of Colorado, Denver | 2020-10-21 |
| Skin Pathology Assessment With Optical Technologies (NCT04295824) | Sheffield Teaching Hospitals NHS Foundation Trust | 2020-08-06 |
| Skin Barrier Assessment in Pregnancy and at Birth (NCT04445298) | National Jewish Health | 2020-08-03 |
| Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema (NCT04156191) | Arcutis Biotherapeutics, Inc. | 2019-12-23 |
| Effects of a Berry Oil Cream on Atopic Eczema and Skin (NCT04085549) | Petra Larmo | 2019-10-09 |
| Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis (NCT03981926) | University of Southern California | 2019-08-27 |
| Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier Function (NCT04097327) | Bitop AG | 2019-08-23 |
| TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE) (NCT03795506) | Imperial College London | 2019-07-08 |
| Study in Subjects With Moderate Atopic Dermatitis (NCT03859986) | Ralexar Therapeutics, Inc. | 2019-03-08 |
| Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK) (NCT03823794) | Momentum Data | 2019-02-01 |
| The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients (NCT03667014) | University of California, San Francisco | 2018-11-01 |
| Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis (NCT03293030) | University of California, San Francisco | 2018-10-22 |
| Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis (NCT03235024) | AOBiome LLC | 2018-01-15 |
| 8-Week Atopic Dermatitis (AD) Treatment Study (NCT03386032) | Procter and Gamble | 2017-11-27 |
| Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis (NCT03540043) | PurGenesis Technologies Inc. | 2017-10-23 |
| Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy (NCT03090178) | Ad scientiam | 2017-06-02 |
| Development of a Method to Measure mRNA Levels in Skin Samples (NCT04537468) | Innovaderm Research Inc. | 2017-05-11 |
| To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin (NCT02857062) | Reckitt Benckiser Healthcare (UK) Limited | 2016-11-23 |
| Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis. (NCT03268174) | AOBiome LLC | 2016-05-11 |
| Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients (NCT03158012) | University of California, San Diego | 2016-04-01 |
| Insulin Sensitivity in Patients With Atopic Dermatitis (NCT03003793) | University Hospital, Gentofte, Copenhagen | 2015-11-01 |
| Atopic Dermatitis Adherence Study (NCT02169986) | University of British Columbia | 2014-08-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Haut-Tief Patient Education on Psoriasis and Eczema (NCT02205593) | University of Zurich | 2012-07-01 |